The rising threat from drug-resistant germs and increasing calls from global health groups for more potent antibiotics is placing a premium on companies such as Cubist. The $4.8 billion drug developer is preparing to introduce four new medicines by 2020.
Lilly expects to soon announce late-stage clinical trial results for two biotech drugs designed to slow the inflammation caused by autoimmune diseases. By the end of the year, it will announce results for a third.
The plant closure will affect 23 plant employees, all of whom will be offered comparable positions at a Lilly plant near Clinton that employs about 500 workers.
HealthLease Properties REIT, which is led by Mainstreet Property’s Zeke Turner, will be sold to Ohio-based Health Care REIT Inc., along with 17 projects Mainstreet has under construction. The deal includes 45 future projects.
U.S. District Judge William T. Lawrence in Indianapolis on Tuesday denied an IRS bid to dismiss that portion of the state’s 2013 lawsuit, in which it claimed the rule illegally conflicts with a provision of the federal law.
The name change will be completed by the end of the year, pending shareholder approval, the company said Tuesday.
Bloomington’s Monroe Hospital, which has had a close relationship with Indianapolis-based St. Vincent Health, filed for bankruptcy reorganization on Friday and plans to sell its business to a Canadian operator.
In spite of the beaucoup bucks in the pharma sector, patients, along with their families and committed advocates, are turning out to be better sources of funding for early stage companies because they tolerate risk better than drug companies and investors.
The decline in patient visits slowed a bit for Indiana University Health in the second quarter, allowing the hospital system to use a price increase and cost cuts to significantly boost its operating profit.
Tens of thousands of military veterans who have been enduring long waits for medical care should be able to turn to private doctors almost immediately under a law signed Thursday.
Founders of Chondrial Therapeutics believe that if further testing validates their treatment for Friedreich’s ataxia, it could be a blockbuster with annual sales topping $1 billion.
Gov. Mike Pence thinks his HIP 2.0 plan would reform Medicaid in line with conservative principles. To the extent the Obama administration agrees, that’s the biggest hurdle to get the plan approved.
An affiliate of Lutheran Health Network in northeast Indiana that concentrates on health-related businesses services expects to nearly triple its workforce.
The NCAA board of directors will vote Thursday on a proposal that would give the five wealthiest college football conferences the ability to make rules and pass legislation without the approval of the rest of Division I schools.
Two insurers announced Tuesday that they are partnering for an ambitious project to establish one of the nation's largest health-information exchanges, an effort they hope will reduce duplication and improve patient outcomes.
State officials met Tuesday with members of the Pokagon Band of Potawatomi Indians in an effort to satisfy federal regulators who are considering a proposed expansion of the state’s low-income health insurance program.
The Indiana Coalition Against Sexual Assault suspended its operations after failing to pay payroll and other taxes, raising alarm that victims will fall through the cracks.
WellPoint saw 218,000 members of its health plans disappear because their employers ended their group plans. Other insurers, however, say small employers are ending their plans more slowly than expected.
Investors seem to have rediscovered the Midwest this year, pouring a record $777 million into 139 companies, according to BioEnterprise. In the first half of 2013, Midwest companies raised $351 million.
The Food and Drug Administration said Friday it will permit Jardiance tablets to be used by adult patients with type 2 diabetes who also are trying to control their condition with diet and exercise.
